Global & USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)

News provided by

02 May, 2014, 15:30 BST

MUMBAI, May 2, 2014 /PRNewswire/ --

Bharat Book Bureau presents Global & USA Cancer Biomarker Market to 2018. It is a comprehensive report on the cancer biomarker industry and its impact on the health system. This report tackles the growing market interest in oncogenic biomarkers, personalized medicine, companion diagnostics and the associated market environment. https://www.bharatbook.com/medical-devices-market-research-reports-489693/

Cancer biomarkers are molecular or genetic moieties (e.g., cells, proteins/peptides, genetic mutations, gene products, enzymes, or hormones) that not only are readily identifiable, but easily quantified in the lab setting. They function primarily to identify or correlate significantly with the severity or occurrence of a certain disease state. The rise in number of oncogenic biomarkers over the last number of years has massive potential in the healthcare industry and serves to propel both the personalized medicine and companion diagnostic markets.

One of the most import aspects of biomarkers is their use to diagnose and assess the progress of disease states in patients. As quantitative markers, these agents also offer the ability to monitor response to certain drug treatments and so are important in the area of personalized medicine.

Individualized, targeted or personalized medicine aims to increase the efficacy of therapeutics via genetic testing and companion diagnostics. Personalized therapeutics and associated companion diagnostics will be more specific and effective thereby giving pharma/biotech companies a significant advantage to recuperate R&D costs. Personalized medicine will reduce the frequency of adverse drug reactions and therefore have a dramatic impact on health economics. Developmental and diagnostic companies will benefit from lower discovery and commercialization costs and more specific market subtypes.

This report describes the current technologies that are propelling the cancer biomarker and companion diagnostic market. It examines the current genetic diagnostic tests and companion diagnostic assays that are in use by the medical and pharmaceutical industry today. Current developments in personalized medicine and the pharmacogenomic revolution are discussed. The emerging trends that appear in the global market and the most developed market (US) are elucidated and analyzed. This study reveals market figures of the overall biomarker market and the cancer biomarker space (2013-2018). Forecast projections and future growth rates are provided to give the reader a forthcoming perspective of this growing industry.

The study also provides a comprehensive financial, business strategy and product review of key players in the cancer biomarker industry. Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.

In summary, the cancer biomarker and associated companion diagnostic market have huge opportunities for growth. This industry will revolutionize the healthcare system and will improve therapeutic effectiveness and reduce the severity of adverse effects. It has enormous potential for investment and the emergence of genetic-based in vitro diagnostics.

Request for sample page: https://www.bharatbook.com/RequestSample.asp?pid=489693

Table of Contents

Executive Summary

Objectives of Report
Data Sources and Methodology
Key Findings and Observations
What Makes Cancer Biomarkers so Important for the Healthcare Industry
What Technologies are Used to Identify Novel Biomarkers
Increase in Cancer Prevalence is Propelling the Oncogenic Biomarker Market
Global and US Economic Impact of Cancer
How Cancer Biomarkers are Revolutionizing Cancer Treatment
What are the most Significant and Strategic Cancer Biomarkers
Global Biomarker Test Market Analysis
Global Cancer Biomarker Market Analysis
Oncology Biomarker Market Main Industry Players
Drivers, Restraints, Opportunities and Challenges of the Cancer Biomarker Market

Global Burden of Cancer

Global Cancer Statistics
Lung Cancer Globally
Lung Cancer Mutation Analysis
Colorectal (Bowel) Cancer Globally
Prostate Cancer Globally
Breast Cancer Globally
Global Economic Impact of Cancer
Cancer in the USA
Breast Cancer in the US
Lung Cancer in the US
Colorectal Cancer in the US
Prostate Cancer in the US
Skin Cancer in the US

Oncogenic Biomarkers - An Overview

Biomarker Discovery to Clinical Validation
Specific Technologies Used in Biomarker Discovery
Proteomics
Mass Spectrometry Based Technologies
Principles of Diagnostic Mass Spectrometry
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Nano LC-MS/MS
MALDI-TOF
Glycomics
Metabolomics
Peptidomics
Enzyme-Linked Immunosorbent Assay (ELISA)
Selected (Multiple) Reaction Monitoring
DNA Based Techniques
Microarrays
Small Molecule Real Time (SMRT) DNA Sequencing
Digital PCR
Next Generation Sequencing
Second-Generation Sequencing Platforms
Whole Genome Sequencing
Epigenomics
Bioinformatics and Next Generation Sequencing
Third Generation Sequencing

Biomarker Validation

Introduction
Phases of Biomarker Validation
Biomarker Validation and Clinical Trials

For more information and complete table of contents:

https://www.bharatbook.com/medical-devices-market-research-reports-489693/

Related Reports

Related Category:

About Bharat Book Bureau

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact us:

Poonam

Bharat Book Bureau

USA/Canada - 1-866-279-8368 (Toll free)

India: +91-22-27810772, 27810773

Blog: http://blog.bharatbook.com

E: poonam@bharatbook.com

W: www.bharatbook.com

SOURCE Bharat Book Bureau